These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1743561)

  • 1. Clear cell adenocarcinoma of the vagina: a second primary in a diethylstilbestrol-exposed woman?
    Goodman A; Sullinger JC; Rice LW; Fuller AF
    Gynecol Oncol; 1991 Nov; 43(2):173-7. PubMed ID: 1743561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent primaries of vaginal clear cell adenocarcinoma and endometrial adenocarcinoma in a 39-year old woman with in utero diethylstilbestrol exposure.
    Keller C; Nanda R; Shannon RL; Amit A; Kaplan AL
    Int J Gynecol Cancer; 2001; 11(3):247-50. PubMed ID: 11437935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary non-clear-cell adenocarcinoma of the vagina in a diethylstilbestrol exposed woman.
    Patel SA; Sunde J
    Mil Med; 2014 Apr; 179(4):e461-2. PubMed ID: 24690973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of clear cell adenocarcinoma of the vagina in pregnancy.
    Davis JA; Wadehra V; McIntosh AS; Monaghan JM
    Br J Obstet Gynaecol; 1981 Mar; 88(3):322-6. PubMed ID: 7470424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary non-clear-cell adenocarcinomas of the vagina in older DES-exposed women.
    DeMars LR; Van Le L; Huang I; Fowler WC
    Gynecol Oncol; 1995 Sep; 58(3):389-92. PubMed ID: 7672708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diethylstilbestrol (DES) exposure. Recommendations of the Diethylstilbestrol-Adenosis (DESAD) Project for the identification and management of exposed individuals.
    Clin Pediatr (Phila); 1983 Feb; 22(2):139-43. PubMed ID: 6822019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of clear cell adenocarcinoma in DES-exposed offspring under observation.
    Kaufman RH; Korhonen MO; Strama T; Adam E; Kaplan A
    Obstet Gynecol; 1982 Jun; 59(6 Suppl):68S-72S. PubMed ID: 7088431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Six years' experience with screening of a diethylstilbestrol-exposed population.
    Mangan CE; Guintoli RL; Sedlacek TV; Rocereto T; Rubin E; Burtnett M; Mikuta JJ
    Am J Obstet Gynecol; 1979 Aug; 134(8):860-5. PubMed ID: 463989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DES-related clear cell adenocarcinoma of the vagina in pregnancy.
    Jones WB; Woodruff JM; Erlandson RA; Lewis JL
    Obstet Gynecol; 1981 Jun; 57(6 Suppl):76S-80S. PubMed ID: 7243130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diethylstilbestrol exposure and the risk of clear cell cervical and vaginal adenocarcinoma.
    Edelman DA
    Int J Fertil; 1989; 34(4):251-5. PubMed ID: 2570761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed onset of clear cell adenocarcinoma of the vagina in DES-exposed progeny.
    Veridiano NP; Tancer ML; Delke I; Gal D; Giannattasio C
    Obstet Gynecol; 1981 Mar; 57(3):395-8. PubMed ID: 7465156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital diethylstilbestrol-associated vaginal/cervical adenosis (DES babies).
    Barclay DL
    J Ark Med Soc; 1979 May; 75(12):451-2. PubMed ID: 156173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions.
    Robboy SJ; Scully RE; Welch WR; Herbst AL
    Arch Pathol Lab Med; 1977 Jan; 101(1):1-5. PubMed ID: 576195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary non-clear cell adenocarcinoma of the vagina in older DES-exposed women.
    Townsend DE
    Gynecol Oncol; 1996 Jun; 61(3):454. PubMed ID: 8641634
    [No Abstract]   [Full Text] [Related]  

  • 15. Vaginal adenosis and adenocarcinoma in mice exposed prenatally or neonatally to diethylstilbestrol.
    Newbold RR; McLachlan JA
    Cancer Res; 1982 May; 42(5):2003-11. PubMed ID: 7066910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol.
    Herbst AL; Anderson D
    Semin Surg Oncol; 1990; 6(6):343-6. PubMed ID: 2263810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diethylstilbestrol (DES)-induced clear cell adenocarcinoma of the vagina metastasizing to the brain.
    Lin LM; Sciubba DM; Gallia GL; Sosnowski J; Weingart JD
    Gynecol Oncol; 2007 Apr; 105(1):273-6. PubMed ID: 17292458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diethylstilbestrol-exposed monozygotic twins discordant for cervicovaginal clear cell adenocarcinoma.
    Sandberg EC; Christian JC
    Am J Obstet Gynecol; 1980 May; 137(2):220-8. PubMed ID: 7189642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of DES-associated clear-cell carcinoma: the importance of regular screening.
    Anderson B; Watring WG; Edinger DD; Small EC; Netland AT; Safaii H
    Obstet Gynecol; 1979 Mar; 53(3):293-9. PubMed ID: 424100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplasia and cytologic findings in 4,589 young women enrolled in diethylstilbestrol-adenosis (DESAD) project.
    Robboy SJ; Szyfelbein WM; Goellner JR; Kaufman RH; Taft PD; Richard RM; Gaffey TA; Prat J; Virata R; Hatab PA; McGorray SP; Noller KL; Townsend D; Labarthe D; Barnes AB
    Am J Obstet Gynecol; 1981 Jul; 140(5):579-86. PubMed ID: 7195652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.